Sensus inks R&D pact with UPenn April 24, 2019 -- Superficial radiation therapy provider Sensus Healthcare has signed an R&D agreement to collaborate with the radiation oncology department at the University of Pennsylvania (UPenn).
Sensus touts research for nonmelanoma skin cancer April 23, 2019 -- Superficial radiation therapy provider Sensus Healthcare is directing attention to the results of a study that assessed the performance of its SRT-100 system for treating nonmelanoma skin cancer patients.
ASRT names recipients of author awards April 22, 2019 -- The American Society of Radiologic Technologists (ASRT) has chosen the winners of its distinguished author awards, which recognize the best articles published in its journals Radiologic Technology and Radiation Therapist.
ViewRay inks Canadian distribution deal April 18, 2019 -- Image-guided radiation therapy developer ViewRay has signed a distribution agreement with Minogue Medical for that company to serve as its exclusive Canadian distributor of the MRIdian system.
Ga-68 PSMA PET/CT for prostate wins Australian favor April 17, 2019 -- When a prostate cancer staging exam is needed, clinicians at one Australian hospital are overwhelmingly choosing PET/CT with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA), according to a study published online April 11 in the Journal of Medical Imaging and Radiation Oncology. Discuss
NRG Oncology receives $95M in NCI funding April 17, 2019 -- The U.S. National Cancer Institute (NCI) has awarded funding of more than $95 million to NRG Oncology to continue its work as a lead protocol organization program.
Alpha Tau receives ISO certification April 11, 2019 -- Israeli radiation therapy technology developer Alpha Tau Medical said it has received International Organization for Standardization (ISO) 13485:2016 certification.
ASTRO hails new anti-self-referral legislation April 11, 2019 -- The American Society for Radiation Oncology (ASTRO) is applauding the introduction of the Promoting Integrity in Medicare Act of 2019, a new bill in the U.S. Congress that would eliminate the in-office exemption for four services -- including advanced imaging and radiation therapy -- from anti-self-referral provisions of the Stark law.
Radiation therapy (RT) could be more effective in African-American men with prostate cancer than previously realized, according to data presented at the American Society for Radiation Oncology (ASTRO) annual meeting. Read more